Acetylcholinesterase Inhibition in Alzheimers Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|3|231-251

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.3, 2004-01, pp. : 231-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2433-2455

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease

By Gauthier S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1511-1520

Informa Healthcare

Access to resources Recommend Favorite

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio   Cavalli Andrea  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite

Chemical synthesis of galantamine, an acetylcholinesterase inhibitor for treatment of Alzheimer’s disease

By Marco-Contelles José   Rodríguez Carolina   García Antonio G  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 575-587

Informa Healthcare

Access to resources Recommend Favorite

Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-09 ,pp. : 267-272

Bentham Science Publishers

Access to resources Recommend Favorite